Roggwil, September 26, 2022 – A research series at the University of Illinois has investigated the connection between tinnitus and blood flow in the brain using magnetic resonance imaging. It could be proven that the severity of tinnitus depends on the blood flow in two brain regions (in the precuneus and in the cingulate cortex).
With the tinniwell sold by Resaphene Suisse AG, blood circulation is promoted by in-ear headphones that are inserted into the auditory canal. The patients consistently report a positive perception of therapy. This is expressed in an improved falling asleep and sleeping through the night and relaxation of the organism. Furthermore, our house was able to observe that without the heat therapy and with the exclusive use of music therapy, the therapy lasted considerably longer or did not work at all.
Due to the current patent situation, this technology cannot be copied and Resaphene is still the only supplier on the market who can offer a functioning tinnitus therapy.
++ About Resaphene Suisse AG
Resaphene Suisse AG, based in Roggwil, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.
++ Contact for questions:
Resaphene Suisse AG
Mrs. Anke Rauterkus (Chief Executive Officer)
T. +41 714500668